Health Care & Life Sciences » Biotechnology | Cancer Genetics Inc.

Cancer Genetics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,610.00
10,199.40
18,040.00
27,049.00
29,121.00
27,470
Cost of Goods Sold (COGS) incl. D&A
4,924.60
8,453.70
14,098.00
17,104.00
18,070.00
18,724
Gross Income
1,685.30
1,745.70
3,942.00
9,945.00
11,051.00
8,746
SG&A Expense
9,528.90
20,014.90
23,929.00
26,596.00
29,516.00
26,786
EBIT
7,843.60
18,269.20
19,987.00
16,651.00
18,465.00
18,040
Unusual Expense
2,834.80
615.00
379.00
1,677.00
2,219.00
2
Non Operating Income/Expense
-
-
-
325.00
266.00
78
Interest Expense
2,387.70
472.80
344.00
454.00
2,050.00
2,120
Pretax Income
13,036.50
18,993.10
21,368.00
15,803.00
22,959.00
20,373
Income Tax
663.90
2,350.20
1,184.00
-
2,079.00
-
Consolidated Net Income
12,372.60
16,642.90
20,184.00
15,803.00
20,880.00
20,373
Net Income
12,372.60
16,642.90
20,184.00
15,803.00
20,880.00
20,373
Net Income After Extraordinaries
12,372.60
16,642.90
20,184.00
15,803.00
20,880.00
20,373
Net Income Available to Common
12,372.60
16,642.90
20,184.00
15,803.00
20,880.00
20,373
EPS (Basic)
3.64
1.80
1.96
1.00
1.01
0.75
Basic Shares Outstanding
4,665.30
9,449.20
10,298.00
15,861.00
20,663.00
27,291
EPS (Diluted)
3.64
1.80
1.96
1.00
1.01
0.75
Diluted Shares Outstanding
4,676.00
9,461.70
10,299.00
15,861.00
20,663.00
27,291
EBITDA
7,517.10
17,430.60
18,325.00
14,276.00
16,300.00
15,926
Non-Operating Interest Income
29.70
73.80
49.00
23.00
63.00
21
Equity in Affiliates (Pretax)
-
939.90
707.00
73.00
22.00
154

About Cancer Genetics

View Profile
Address
Meadows Office Complex
Rutherford New Jersey 07070
United States
Employees -
Website http://www.cancergenetics.com
Updated 07/08/2019
Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomaker solutions, biorepository solutions, consulting, cytogenetics testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.